Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
insulin
Pharma
Lilly plots European discontinuations of certain insulin products
The retreat, which includes versions of Humalog and Abasaglar, comes as Lilly increasingly leans on its high-growth GLP-1 portfolio.
Zoey Becker
Mar 24, 2026 11:52am
Fierce Healthcare
FTC, Express Scripts reach settlement in insulin pricing case
Feb 4, 2026 12:35pm
Sanofi expands price cut to $35 monthly for all insulin products
Sep 26, 2025 1:00pm
With strong data, Lilly plots filings for weekly insulin asset
Jun 23, 2025 10:16am
Schott Pharma invests €100M in Hungary manufacturing expansion
Jun 5, 2025 9:40am
Sanofi gains FDA nod for first biosimilar version of NovoLog
Feb 18, 2025 11:05am
Fierce Healthcare
Fierce Healthcare
Fierce Healthcare
Fierce Healthcare
